Dan is the Founder and Chief Executive Officer of UNIQ Trials, bringing over 20 years of experience across global CRO operations, clinical-stage biotech leadership, and venture-backed company building. His career began within leading global CROs and US-based biotech organizations, where he developed a deep understanding of how sponsors evaluate outsourcing partners, navigate funding milestones, and make critical go/no-go decisions on clinical programs.

In 2015, he founded UNIQ Trials with a clear vision: to build a global boutique CRO model that delivers senior-level attention, transparent communication, and inspection-ready quality to emerging and mid-sized biotech companies. Under his leadership, UNIQ Trials has become a trusted partner to venture-backed and public biotechs seeking strategic alignment alongside operational excellence.

A natural builder of teams and partnerships, he is passionate about cultivating senior, cross-functional leadership groups that operate with agility, accountability, and sponsor-centric focus. His strategic insight, operational discipline, and commitment to high-quality delivery position UNIQ Trials as a partner of choice for innovative biotech companies advancing the future of medicine.